Join to View Full Profile
50 Staniford StSte 200Boston, MA 02114
Phone+1 617-726-2914
Fax+1 617-724-2135
Dr. Sober is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1972 - 1974
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1968 - 1970
George Washington University School of Medicine and Health SciencesClass of 1968
Certifications & Licensure
MA State Medical License 1972 - 2027
American Board of Dermatology Dermatology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014, 2016-2017
Clinical Trials
- Post-Approval Study of MelaFind Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- 4 citationsHistologic margin status is a predictor of relapse in lentigo maligna melanoma.Mai P Hoang, Pawel Karpinski, Miguel Zúñiga-Castillo, Ruth K Foreman, Kevin S Emerick
Journal of the American Academy of Dermatology. 2023-11-01 - 26 citationsEarly Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry
JAMA Dermatology. 2023-05-01 - 10 citationsSurgical Delay and Mortality for Primary Cutaneous Melanoma.Samantha M. Guhan, Genevieve M. Boland, Kenneth K. Tanabe, William M. Lin, Bobby Y. Reddy
Journal of the American Academy of Dermatology. 2021-04-01
Other
- Lentigo maligna: Clinical manifestations, diagnosis, and managementSober AJ, Olbricht S
http://www.uptodate.com/contents/lentigo-maligna-clinical-manifestations-diagnosis-and-management
UpToDate, Wolters Kluwer Health - 2012-03-22
Press Mentions
- Guidelines of Care for the Management of Primary Cutaneous MelanomaJanuary 1st, 2019
In GeneralFebruary 12th, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
